Innovation Led, Compliance Rooted | Wuhan Jinglong Biotechnology 2026 Global Exhibition Tour Grandly Launched – Inviting Global Partners for Win‑Win Cooperation

As an innovative pioneer in the pet oral dispersible film sector, Wuhan Jinglong Biotechnology focuses on the pet health care industry, specializing in R&D of innovative pet oral dispersible film dosage forms and professional OEM/ODM manufacturing services. Since its establishment, the company has anchored its development by international standards and strictly abided by industry regulations throughout the entire process.

The company has obtained three major certifications: HACCP, ISO22000, and cGMP, completed U.S. FDA registration and review, and secured full qualifications for overseas export. It has built a Class 100,000 GMP clean workshop and a standardized production management system equipped with high‑precision laboratory testing instruments. With strict control covering the full chain from R&D, production to quality control, Jinglong has solidified its product quality foundation with strong compliance capabilities and professional technical configuration, making it a trustworthy emerging manufacturing partner for pet brands worldwide.

In March 2026, the company stepped onto the international stage for the first time with its core pet oral dispersible film products at the Global Pet Expo in Orlando, USA. It impressed the audience with innovative dosage forms and robust product strength, marking a crucial step in its global brand layout.

Building on this momentum to embark on a new global journey, starting from April 2026, Wuhan Jinglong Biotechnology officially launches its full‑year global exhibition plan. It will participate in key global pet expos in Dubai, Nuremberg (Germany), Las Vegas (USA), Jakarta (Indonesia), as well as major domestic events in Shanghai, Beijing, Chengdu, and Guangzhou. This fully covers markets in the Middle East, Europe, North America, Southeast Asia and China, deeply connecting global pet industry resources.

In this global exhibition tour, the company will prominently showcase its core pet oral dispersible film products featuring innovative fast‑dissolving dosage forms, high palatability and multi‑scene adaptability, together with full‑chain OEM/ODM services including formula customization, sample proofing, large‑scale production and cross‑border supply.

With core strengths of innovative product competitiveness, full qualification compliance, high‑precision laboratory equipment and a mature service system, it provides global partners with customized and professional pet health care solutions.

Gathering new strengths to open a new chapter!

Wuhan Jinglong Biotechnology sincerely invites domestic and international pet brands, distributors and buyers to visit its booths at various exhibitions for face‑to‑face cooperation discussions. Let us explore new opportunities in the innovative pet oral dispersible film sector, empower the development of the pet industry through innovation, and jointly create a new future in the global pet market!